NCT07244159 Effects of Dynamic Surface Exercise Training in Children With Diplegic Cerebral Palsy
| NCT ID | NCT07244159 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Child, Only |
| Study Type | INTERVENTIONAL |
| Enrollment | 14 participants |
| Start Date | 2025-10-22 |
| Primary Completion | 2026-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 14 participants in total. It began in 2025-10-22 with a primary completion date of 2026-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Data will be collected after the approval of synopsis a total of 14 children with diplegic cerebral palsy of age between 6 and 8 years of both genders with Gross Motor Function Classification System of level III and IV will be recruited to participate in randomized controlled study. The study will be completed within 10 months after the approval of the synopsis. Technique of the study is non-probability convenient sampling technique. Recruited will be randomly divided into two groups, dynamic surface exercise training (DSET) group and standard physiotherapy training group. Both the groups receive active training program lasting for 60 minutes, 4 days/week for 6 weeks who have the ability to follow and accept verbal instructions. Gross Motor Function Measure (GMFM)-88 and Pediatric Balance Scale (PBS) and Time up and go test scores will be recorded at baseline, and at the end of 6-week post-intervention.
Eligibility Criteria
Inclusion Criteria: * Age between 5 and 8 years of both genders * Classification as level III and IV on the Gross Motor Function Classification system (GMFCS) Exclusion Criteria: * • Any orthopedic surgery or botulinum toxin injection in the past 6 months. * Refusal by the parents to participate.
Contact & Investigator
Hafiza Iram Batool, MS-PT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07244159 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 8 Years, studying Child, Only. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07244159 currently recruiting?
Yes, NCT07244159 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07244159 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07244159 clinical trial?
NCT07244159 is sponsored by Riphah International University. The principal investigator is Hafiza Iram Batool, MS-PT at Riphah International University. The trial plans to enroll 14 participants.